Sumatriptan Succinate Tablet
Product Images NDC 55111-292

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 55111-292). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Packaging label for Sumatriptan Tablets USP 25 mg by Dr. Reddy's Laboratories Limited. The label shows a unit of use blister pack containing 27 tablets (3 strips of 9). It includes storage instructions, usual dosage notes, and a barcode. The design features the proprietary name and strength prominently, with the manufacturer's logo.*

FDA Label Image

Carton2 (Carton2)

Packaging label for Sumatriptan Tablets, USP 50 mg by Dr. Reddy's Laboratories Limited. This is a Unit of Use Blister Pack containing 27 tablets (3 strips of 9 tablets each). The label includes dosage form, strength, NDC 55111-292-98, and storage instructions. It also features a pharmacy label area, barcode, and patient instructions with images.*

FDA Label Image

Carton3 (Carton3)

Packaging label for Sumatriptan Tablets USP 100 mg by Dr. Reddy's Laboratories Limited. The label indicates a unit of use blister pack of 27 tablets (3 x 9) with instructions to swallow tablets whole and store between 20°-25°C. The label also includes NDC 55111-293-98 and emphasizes tablets are for prescription use only.*

FDA Label Image

Container1 (Container1)

Sumatriptan Tablets, USP 25 mg oral tablets packaging label by Dr. Reddy's Laboratories Limited. The label shows a 36-tablet bottle with instructions for storage, dosage, and patient information access via a QR code and website. The label features the strength prominently in orange text alongside the proprietary and generic name and NDC 55111-291-36.*

FDA Label Image

Container2 (Container2)

Label for Sumatriptan Tablets USP 50 mg by Dr. Reddy's Laboratories Limited. The label indicates a package containing 36 oral tablets. It includes the product's NDC number, usage instructions to not split or chew the tablet, and a QR code for the patient information sheet.*

FDA Label Image

Container3 (Container3)

Label for Sumatriptan Tablets, USP 100 mg by Dr. Reddy's Laboratories Limited, containing 36 oral tablets. The label includes a barcode, NDC 55111-293-36, usage instructions, storage conditions, and a QR code for patient information.*

FDA Label Image

Figure1

A line graph illustrating the estimated probability of response over time in minutes from the initial dose, comparing placebo with Sumatriptan Succinate oral tablet doses of 25 mg, 50 mg, and 100 mg. The probability of response increases with time for all doses, with higher doses showing greater response rates compared to placebo.*

FDA Label Image

Figure2

A line graph showing the estimated probability of remediation or rescue over time in hours from the initial dose for placebo and Sumatriptan Succinate tablets at strengths 25 mg, 50 mg, and 100 mg. The y-axis represents the estimated probability percentage from 0% to 100%, and the x-axis shows time in hours from initial dose up to 24 hours.*

FDA Label Image

Structure (Structure)

Chemical structure of Sumatriptan Succinate showing its molecular components and arrangement as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.